Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 587
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
LV Butasal-100 - V/NRP/13/0018 UAB "Interchemie werken "De Adelaar" LT", Lietuva QA12CX99 cattle; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cyanocobalamin,Butaphosphan
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 02-Feb-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 27092019LI (27-Sep-2019)
Labelling text: [PDF] 27092019M (27-Sep-2019)
Summary of product characteristics: [PDF] 27092019ZA (27-Sep-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/13/0018-01 100 mg/ml 1 Stikla (tumša) flakons, 50 ml -
V/NRP/13/0018-02 100 mg/ml 1 Stikla (tumša) flakons, 100 ml -
LV Glucortin-20 2 mg/ml V/NRP/12/0040 Interchemie werken „De Adelaar“ LT, Lietuva QH02AB02 cattle; pigs; goats; dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Dexamethasone sodium phosphate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 04-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 26102021LI (26-Oct-2021)
Labelling text: [DOCX] 26102021M (26-Oct-2021)
Summary of product characteristics: [DOCX] 26102021ZA (26-Oct-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/12/0040-01 2 mg/ml 1 Stikla pudele ar Al vāciņu, 50 ml -
Cazitel Plus - V/MRP/09/0029 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Praziquantel, Pyrantel embonate, Febantel
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 08-Apr-2014
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (25-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/09/0029-01 1 Blisteris, 2 tablete -
V/MRP/09/0029-02 2 Blisteris, 2 tablete -
V/MRP/09/0029-03 3 Blisteris, 2 tablete -
V/MRP/09/0029-04 1 Blisteris, 8 tablete -
V/MRP/09/0029-05 5 Blisteris, 2 tablete -
V/MRP/09/0029-06 6 Blisteris, 2 tablete -
V/MRP/09/0029-07 7 Blisteris, 2 tablete -
V/MRP/09/0029-08 2 Blisteris, 8 tablete -
V/MRP/09/0029-09 9 Blisteris, 2 tablete -
V/MRP/09/0029-10 10 Blisteris, 2 tablete -
V/MRP/09/0029-11 3 Blisteris, 8 tablete -
V/MRP/09/0029-12 14 Blisteris, 2 tablete -
V/MRP/09/0029-13 15 Blisteris, 2 tablete -
V/MRP/09/0029-14 4 Blisteris, 8 tablete -
V/MRP/09/0029-15 18 Blisteris, 2 tablete -
V/MRP/09/0029-16 5 Blisteris, 8 tablete -
V/MRP/09/0029-17 21 Blisteris, 2 tablete -
V/MRP/09/0029-18 22 Blisteris, 2 tablete -
V/MRP/09/0029-19 6 Blisteris, 8 tablete -
V/MRP/09/0029-20 25 Blisteris, 2 tablete -
Procapen Injector 3 g V/DCP/12/0034 aniMedica GmbH, Vācija QJ51CE09 cattle Vairāk

Medicinal product information

Pharmaceutical form: intramammary suspension
International name (active substance): Procaine benzylpenicillin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija;Industrial Veterinaria, S.A., Spānija
Date of authorisation/renewal: 04-Apr-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0034-01 3 g/deva 24 Injektors, 1 deva -
PGF Veyx 0.0875 mg/ml V/DCP/12/0038 Veyx-Pharma GmbH, Vācija QG02AD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
Date of authorisation/renewal: 03-Oct-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0038-01 0,0875 mg/ml 1 Stikla pudelīte, 10 ml -
V/DCP/12/0038-02 0,0875 mg/ml 1 Stikla pudelīte, 20 ml -
V/DCP/12/0038-03 0,0875 mg/ml 1 Stikla pudelīte, 50 ml -
PGF Veyx forte 0.250 mg/ml V/DCP/12/0039 Veyx-Pharma GmbH, Vācija QG02AD90 cattle; pigs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Cloprostenol sodium
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Veyx-Pharma GmbH, Vācija;Veyx-Pharma B.V., Nīderlande
Date of authorisation/renewal: 03-Oct-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jun-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (16-Jun-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (12-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/12/0039-01 0,25 mg/ml 1 Stikla pudelīte, 10 ml -
V/DCP/12/0039-02 0,25 mg/ml 1 Stikla pudelīte, 20 ml -
V/DCP/12/0039-03 0,25 mg/ml 1 Stikla pudelīte, 50 ml -
BIOSUIS M.hyo - V/MRP/13/0001 Bioveta, a.s., Čehija QI09AB13 pigs

Medicinal product information

Pharmaceutical form: emulsion for injection
International name (active substance): Inactivated Mycoplasma hyopneumoniae
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bioveta, a.s., Čehija
Date of authorisation/renewal: 04-Oct-2016
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2026)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Apr-2026)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Apr-2026)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/13/0001-01 10 Stikla flakons (kartona kastē), 5 deva -
V/MRP/13/0001-02 1 Stikla flakons (kartona kastē), 50 deva -
V/MRP/13/0001-03 1 ABPE pudele kartona kastē, 125 deva -
V/MRP/13/0001-04 10 Stikla flakons (plastmasas kastē), 5 deva -
V/MRP/13/0001-05 1 ABPE flakons (kartona kastē), 50 deva -
V/MRP/13/0001-06 10 ABPE flakons (kartona kastē), 5 deva -
V/MRP/13/0001-07 10 ABPE flakons (plastmasas kastē), 5 deva -
Mucosiffa - V/MRP/20/0011 Ceva Sante Animale,, Francija QI02AD02 cattle Vairāk

Medicinal product information

Pharmaceutical form: lyophilisate and solvent for suspension for injection
International name (active substance): Live, attenuated Bovine Viral Diarrhoea type BVD-1virus, cytopath. strain Oregon C24
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Dec-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Dec-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Dec-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0011-01 1 Stikla flakons, 1 deva -
V/MRP/20/0011-02 1 Stikla flakons, 2 deva -
V/MRP/20/0011-03 1 Stikla flakons, 5 deva -
V/MRP/20/0011-04 1 Stikla flakons, 10 deva -
V/MRP/20/0011-05 1 Stikla flakons, 20 deva -
V/MRP/20/0011-06 1 Stikla flakons, 50 deva -
Karallact 75 mg V/NRP/15/0005 Fatro S.p.A., Itālija QJ51DE90 cattle (lactating cows) Vairāk

Medicinal product information

Pharmaceutical form: intramammary ointment
International name (active substance): Cefquinome (as cefquinome sulfate)
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 01-Oct-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Oct-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/15/0005-01 75 mg 4 Polipropilēna pilnšļirce, 1 deva -
V/NRP/15/0005-02 75 mg 15 Polipropilēna pilnšļirce, 1 deva -
V/NRP/15/0005-03 75 mg 24 Polipropilēna pilnšļirce, 1 deva -
Ovulike 0.004 mg/ml V/MRP/17/0045 aniMedica GmbH, Vācija QH01CA90 cattle; horses; rabbits Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Buserelin acetate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release aniMedica GmbH, Vācija
Date of authorisation/renewal: 29-Mar-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_aprakst (27-Jul-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_aprakst (27-Jul-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (30-Dec-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/17/0045-01 5 Stikla flakons, 10 ml -
V/MRP/17/0045-02 50 Stikla flakons, 10 ml -
V/MRP/17/0045-03 100 Stikla flakons, 10 ml -
V/MRP/17/0045-04 250 Stikla flakons, 10 ml -
V/MRP/17/0045-05 500 Stikla flakons, 10 ml -
Advantix 100mg/500mg - V/NRP/25/0057 Elanco Animal Health GmbH, Vācija QP53AC54 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 29-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/25/0057-01 1 Pipete, 1 ml -
V/NRP/25/0057-02 2 Pipete, 1 ml -
V/NRP/25/0057-03 3 Pipete, 1 ml -
V/NRP/25/0057-04 4 Pipete, 1 ml -
V/NRP/25/0057-05 6 Pipete, 1 ml -
Advantix 250mg/1250mg - V/NRP/25/0058 Elanco Animal Health GmbH, Vācija QP53AC54 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 29-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/25/0058-01 1 Pipete, 2,5 ml -
V/NRP/25/0058-02 2 Pipete, 2,5 ml -
V/NRP/25/0058-03 3 Pipete, 2,5 ml -
V/NRP/25/0058-04 4 Pipete, 2,5 ml -
V/NRP/25/0058-05 6 Pipete, 2,5 ml -
Advantix 400mg/2000mg - V/NRP/25/0059 Elanco Animal Health GmbH, Vācija QP53AC54 dogs Vairāk

Medicinal product information

Pharmaceutical form: spot-on solution
International name (active substance): Imidacloprid, Permethrin
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release KVP Pharma + Veterinar Produkte GmbH, Vācija
Date of authorisation/renewal: 29-Dec-2008
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (10-Sep-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (10-Sep-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/25/0059-01 1 Pipete, 4 ml -
V/NRP/25/0059-02 2 Pipete, 4 ml -
V/NRP/25/0059-03 3 Pipete, 4 ml -
V/NRP/25/0059-04 4 Pipete, 4 ml -
V/NRP/25/0059-05 6 Pipete, 4 ml -
Moxisolv LA 100 mg/ml V/DCP/23/0006 Bimeda Animal Health Limited, Īrija QP54AB02 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Moxidectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bimeda Animal Health Limited, Īrija
Date of authorisation/renewal: 23-Feb-2023
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/23/0006-01 100 mg/ml 1 ABPE pudele, 50 ml -
V/DCP/23/0006-02 100 mg/ml 1 ABPE pudele, 200 ml -
Micospectone - V/NRP/01/1379 Fatro S.p.A., Itālija QJ01FF52 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Lincomycin hydrohloride, Spectinomycin hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (03-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1379-01 1 Stikla flakons, 50 ml -
V/NRP/01/1379-02 1 Stikla flakons, 100 ml -
V/NRP/01/1379-03 1 Stikla flakons, 250 ml -
V/NRP/01/1379-04 1 Stikla flakons, 500 ml -
Milpro 4 mg/10 mg - V/MRP/20/0025 VIRBAC, Francija QP54AB51 small cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_aprakst (22-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0025-01 4 mg/10 mg 1 Al/Al blisteris, 2 tablete -
V/MRP/20/0025-02 4 mg/10 mg 2 Al/Al blisteris, 2 tablete -
V/MRP/20/0025-03 4 mg/10 mg 12 Al/Al blisteris, 2 tablete -
Milpro 16 mg/40 mg - V/MRP/20/0026 VIRBAC, Francija QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (22-Aug-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (22-Aug-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0026-01 16 mg/40 mg 1 Al/Al blisteris, 2 tablete -
V/MRP/20/0026-02 16 mg/40 mg 2 Al/Al blisteris, 2 tablete -
V/MRP/20/0026-03 16 mg/40 mg 12 Al/Al blisteris, 2 tablete -
V/MRP/20/0026-04 16 mg/40 mg 24 Al/Al blisteris, 2 tablete -
Milpro 2,5 mg/ 25 mg - V/MRP/20/0027 VIRBAC, Francija QP54AB51 small dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (24-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (24-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/20/0027-01 2,5 mg/25 mg 1 Al/Al blisteris, 2 tablete -
V/MRP/20/0027-02 2,5 mg/25 mg 2 Al/Al blisteris, 2 tablete -
V/MRP/20/0027-03 2,5 mg/25 mg 12 Al/Al blisteris, 2 tablete -
Fatroximin 300/4 mg/g - V/NRP/01/1369 Fatro S.p.A., Itālija QG51AA06 cattle; horses Vairāk

Medicinal product information

Pharmaceutical form: pessary
International name (active substance): Rifaximin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (11-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (11-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1369-01 300 mg/pesārijs 12 Blisteris, 1 pesārijs -
V/NRP/01/1369-02 300 mg/pesārijs 36 Blisteris, 1 pesārijs -
Fatroximin 100/13.4 mg/g - V/NRP/01/1371 Fatro S.p.A., Itālija QG51AA06 mares; cows Vairāk

Medicinal product information

Pharmaceutical form: intrauterine foam
International name (active substance): Rifaximin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Fatro S.p.A., Itālija
Date of authorisation/renewal: 04-Jul-2011
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Nov-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Nov-2025)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/01/1371-01 100 mg/deva 6 Alumīnija balons, 1 deva -

3082 records

© Food and veterinary service · 2026 Cookies policy